Healius Ltd | HLS

Healius Ltd traded at 3.69 this Thursday July 7th, decreasing 0.01 or 0.27 percent since the previous trading session. Looking back, over the last four weeks, Healius Ltd lost 1.60 percent. Over the last 12 months, its price fell by 20.82 percent. Looking ahead, we forecast Healius Ltd to be priced at 3.57 by the end of this quarter and at 3.32 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
3.69
Daily Change
-0.27%
Yearly
-20.82%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Ansell 23.25 0.38 1.66% -43.87%
Capitol Health Ltd 0.29 0.01 1.75% -21.62%
Cochlear 203.01 0.03 0.01% -17.63%
CSL 285.70 -0.43 -0.15% 2.35%
Fisher Paykel Healthcare 21.24 0.05 0.24% -29.15%
Integral Diagnostics Ltd 3.00 0.03 1.01% -41.86%
Mayne Pharma 0.29 0 0% -14.93%
Nanosonics Ltd 3.92 -0.05 -1.14% -25.43%
Polynovo Ltd 1.47 -0.02 -1.01% -38.24%
Ramsay Health Care 70.00 -0.84 -1.19% 8.73%
ResMed 32.25 -0.26 -0.78% -3.78%
Sonic Healthcare 33.40 0.02 0.06% -11.34%
Sigma Healthcare Ltd 0.59 0 0% -5.65%

Indexes Price Day Year
AUALL 6787 2.30 0.03% -10.88%
AU200 6597 2.96 0.04% -10.13%

Healius Ltd
Healius Limited is an Australia-based healthcare company. The Company operates through three segments: Pathology, Imaging and Day Hospitals. Pathology segment provides pathology services. Imaging segment offers imaging and scanning services from imaging sites, hospitals and from within the consolidated entity's medical centers. Day Hospitals segment is an operator of day hospitals and hematology or oncology services and provides services and facilities to In-Vitro Fertilization (IVF) specialists. The Company also provides facilities and support services to general practitioners, radiologists and a range of other healthcare professionals, enabling them to care their patients in partnership with the Company's pathologists, nurses and other employees.